Safety, Tolerability and Pharmacokinetics of Second Generation VIR-7831 Material in Non-hospitalized Participants With Mild to Moderate COVID-19

NCT04779879 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
354
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Vir Biotechnology, Inc.

Collaborators